Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Classical hematology 5Gastrointestinal 3Thoracic 2Plasma cell 1Myeloid 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 3126Triple Negative Breast Neoplasms 513Ovarian Neoplasms 230Colorectal Neoplasms 188Carcinoma, Non-Small-Cell Lung 188Prostatic Neoplasms 183Neoplasms 175Neoplasm Metastasis 164Lung Neoplasms 164Melanoma 118Stomach Neoplasms 114Pancreatic Neoplasms 113Endometrial Neoplasms 107Uterine Cervical Neoplasms 94Squamous Cell Carcinoma of Head and Neck 87Colonic Neoplasms 82Carcinoma, Intraductal, Noninfiltrating 82Head and Neck Neoplasms 81Sarcoma 62Breast Carcinoma In Situ 62Carcinoma, Renal Cell 61Urinary Bladder Neoplasms 60Motor Activity 59Esophageal Neoplasms 58Brain Neoplasms 50Lymphedema 44Breast Cancer Female 41Liver Neoplasms 39Advanced Breast Cancer 38Lymphoma 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Breast × 1 year × Clear all
NCT07380646 2026-04-30

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
94 enrolled
Breast

Breast Neoplasms, Leukopenia, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡